Clinical trials / NCT05208047
NCT05208047Phase 3Recruiting

(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors

Study sponsor: Cogent Biosciences, Inc. · COGT

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov recordCSV export · Pro
Primary completion2025-09-30Actual
Enrollment · participants482Estimated
Source updated2026-06-16Last update listed in the registry record
Version history

Changes to this trial

Last 12 months
Pro unlocks the full available history and CSV export. View Pro features

· 1 field changed

Recruitment status changed

− Before

Active not recruiting

+ After

Recruiting

Check registry source

· 1 field changed

Planned enrollment increased by 40 participants

− Before

442 participants (planned)

+ After

482 participants (planned)

Check registry source

· 2 fields changed

Completion date type changed

− Before

Estimated

+ After

Actual

Primary completion date changed

− Before

Jul 2025

+ After

30 Sep 2025

Check registry source